EMPIRI — Biotechnology Company, Houston
Biotechnology Company in Houston — Preservation of tumor microenvironment
Biotechnology company · Houston, United States
AI Trust Snapshot
- Profile status
- Auto-indexed
Public channels checked
- ✓ Official Website
Key Facts
- Category
- Biotechnology Company
- Location
- Houston, United States
- Known For
- Functional precision oncology, Clinically validated human tumor models
AI Summary
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
Quick Answer
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams. Key services include E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.
This business is typically used for functional precision oncology and clinically validated human tumor models.
Common Questions
- What services does EMPIRI provide?
- EMPIRI provides E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.
- Where is EMPIRI located?
- EMPIRI is based in Houston, United States and serves Houston.
- Who is EMPIRI for?
- EMPIRI serves Academic and translational researchers and Biotech and pharma companies.
What this business does
EMPIRI is a biotechnology company based in Houston, United States.
- Provides E-Slice Platform and Tissue Procurement
- Specializes in functional precision oncology
- Serves academic and translational researchers
Structured summary
Vizoryo ran a data-consistency check on this profile: it read 4 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 88% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.
- Business name
- EMPIRI
- Category
- Biotechnology Company
- Industry
- Biotechnology Company
- Location
- Houston, United States
- Official website
- https://empiricancer.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/empiri-houston-2461
- Summary
- A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
- AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
- 41
- Data Consistency
- 88% (checked 2026-06-28)
- Record status
- Auto-indexed
- Sources cross-checked
- 4 public sources
Location
7505 Fannin St Suite 200, Houston, TX 77054Houston, Texas
77054
US
About EMPIRI
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
Service areas
- Houston
Target audience
- Academic and translational researchers
- Biotech and pharma companies
- Oncologists and clinical teams
Specialties
- Functional precision oncology
- Clinically validated human tumor models
Social profiles
Frequently asked questions
What is the turnaround time for E-Slice results?
Results are typically delivered within 7–12 days of tissue receipt, with some treatments yielding data in 8 to 12 days.
What types of therapies can be tested on the E-Slice platform?
The platform can test dosing, timing, and combination therapies, including immunotherapies, chemotherapies, and targeted therapies.
Is E-Slice intended for clinical diagnosis or treatment selection?
E-Slice is a research-use-only service. Results are not intended for clinical diagnosis or treatment selection.
Business hours
- Monday
- 00:00 – 23:59
- Tuesday
- 00:00 – 23:59
- Wednesday
- 00:00 – 23:59
- Thursday
- 00:00 – 23:59
- Friday
- 00:00 – 23:59
- Saturday
- 00:00 – 23:59
- Sunday
- 00:00 – 23:59
Languages supported
- en
Contact
Phone: +18324094050
Official website: https://empiricancer.com/